Efficacy and safety of ixekizumab in a phase III, randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis (IXORA‐PEDS)...

por Paller, A.S., Seyger, M.M.B., Alejandro Magariños, G., Bagel, J., Pinter, A., Cather, J., Keller, S., Rodriguez Capriles, C., Gontijo Lima, R., Gallo, G., Little, C.A., Edson‐Heredia, E., Li, L., Xu, W., Papp, K.
Publicado 2020